The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: Evidence for decreased chloroquine metabolism in volunteers with pruritus

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 3, 2000, Pages 237-241

  Ademowo, O G ^a   Sodeinde, O ^b   Walker, O ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE;

ADULT; ARTICLE; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; VOLUNTEER;

EID: 0034122969     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.104257     Document Type: Article

References (18)

1. 1. Alvan G, Ekman L, Lindstrom B. Determination of chloroquine and its desethyl metabolite in plasma, red cell and urine by liquid chromatography. J Chromatogr 1982;229:241-7.
2. 2. Bergvist Y, Domeij-Nyberg B. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determinations of these compounds in serum and plasma. J Chromatogr 1983;272:137-48.
3. 3. Gustafsson LL, Walker O, Alvan G, Beerman B, Estevez F, Gleisner L, et al. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 1984;22:31-6.
4. 4. Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B. The single dose pharmacokinetics of chloroquine and its major desethyl metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 1984;26:521-30.
5. 5. Walker O. Salako LA, Alvan G, Ericsson O, Sjoqvist F. The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol 1987;23:295-301.
6. 6. Sowunmi A, Walker O, Salako LA. Pruritus and antimalarial drugs in Africans [letter]. Lancet 1989:2:213.
7. 7. Olatunde A. The practical and therapeutical aspects of chloroquine-induced itching in tropical Africa. Afr J Med Med Sci 1977;6:27-31.
8. 8. Osifo NG. Mechanisms of enhanced pruritogenicity of chloroquine among patients with malaria: a review. Afr J Med Med Sci 1989;18:121-9.
9. 9. Ademowo OG, Walker O, Sodeinde O. Prevalence of chloroquine-induced pruritus: evidence for heredofamilial factors. Malaria Inf Dis Afr 1998;8:14-8.
10. 10. Ekanem OJ, Weisfeld JS, Salako LA, Nahlen BL, Ezedinachi EN, Walker O, et al. Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ 1990; 68:45-52.
11. 11. Ajayi AA, Akinleye AO, Udoh SJ, Ajayi OO, Oyelese O, Ijaware CO. The effects of prednisolone and niacin on chloroquine induced pruritus in malaria. Eur J Clin Pharmacol 1991;41:383-5.
12. 12. Olatunde IA. Chloroquine concentration in skin of rabbits and man. Br J Pharmacol 1971;43:335-40.
13. 13. Essien EE, Ette EL, Thomas WOA, Brown-Awala EA. Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine induced pruritus. Eur J Drug Metab Pharmacokinet 1989; 14:71-7.
14. 14. Lindquist NG, Ullberg S. The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol 1972;31(suppl 12):1-31.
15. 15. Taylor GO, Oyediran AB, Saliu I. Effects of haemoglobin electrophoretic pattern and seasonal changes on urine concentration in young adult Nigerian males. Afr J Med Med Sci 1978;7:201-5.
16. 16. Walker O, Ademowo OG. A rapid cost-effective liquid chromatographic method for the determination of chloroquine and desethyl-chloroquine in biological fluids. Ther Drug Monit 1996;78:92-6.
17. 17. Salako LA. Toxicity and side-effects of antimalarials in Africa: a critical review. Bull World Health Organ 1984: (suppl)62:63-8.
18. 18. Walker O, Dawodu AH, Adeyokunnu AA, Salako LA, Alvan G. Plasma chloroquine and desethylchloroquine concentration in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol 1983:16;701-5.